Literature DB >> 25740071

A relation between cell cycle and intestinal metaplasia in oesophageal biopsies using optical and digital microscopy.

Miklós Máté1, Béla Molnár.   

Abstract

Protein expression changes in relation to cell cycles provide important information, and it may represent a new method for an early diagnosis of metaplasia - dysplasia - adenocarcinoma sequence. We investigated potential changes in cell cycle genes such as protooncogenes (PCNA, EGFR), tumour suppressor gene (p53), apoptotic TUNNEL (Tdt mediated dUTP nick and labelling) gene, as well as small intestinal mucus antigen (SIMA) and large intestinal mucus antigen (LIMA), which accumulates in metaplastic epithelium due to the inflammatory process in routine oesophageal biopsies using immunohistochemistry. Oesophageal biopsies were taken from patients with Barrett's oesophagus (n = 30), reflux oesophagitis (n = 30), healthy oesophagus (n = 30) and healthy cardia (n = 10). Immunohistochemical signalling was carried out by Streptavidin-Biotin-AEC (aminoetil-carbazol). Expression of PCNA was statistically significantly lower in healthy oesophagus (p < 0.05) versus reflux oesophagitis and Barrett's oesophagus. However, no significant change was detected in the expression of SIMA and LIMA in intestinal metaplasia. Further, EGFR, p53 and TUNNEL levels were significantly different in healthy versus Barrett's oesophagus. Manual counting using virtual microscopy was comparable with the result using conventional light microscopy, but the former is significantly quicker. There was no difference between manual and automated cell counting (p > 0.05).

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25740071     DOI: 10.1007/s12253-014-9873-8

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  22 in total

1.  P53 mutational status improves estimation of prognosis in patients with curatively resected adenocarcinoma in Barrett's esophagus.

Authors:  P M Schneider; O Stoeltzing; J A Roth; A H Hoelscher; S Wegerer; S Mizumoto; K Becker; H J Dittler; U Fink; J R Siewert
Journal:  Clin Cancer Res       Date:  2000-08       Impact factor: 12.531

2.  Analysis of the premalignant stages of Barrett's oesophagus through to adenocarcinoma by comparative genomic hybridization.

Authors:  Jeanette Croft; Elizabeth M Parry; Gareth J Jenkins; Shareen H Doak; John N Baxter; A Paul Griffiths; Tim H Brown; James M Parry
Journal:  Eur J Gastroenterol Hepatol       Date:  2002-11       Impact factor: 2.566

3.  Gene amplification and protein overexpression of c-erb-b2 in Barrett carcinoma and its precursor lesions.

Authors:  Helene Geddert; Mohamed Zeriouh; Marietta Wolter; Joachim W Heise; Helmut E Gabbert; Mario Sarbia
Journal:  Am J Clin Pathol       Date:  2002-07       Impact factor: 2.493

Review 4.  Barrett's oesophagus: from metaplasia to dysplasia and cancer.

Authors:  J-F Fléjou
Journal:  Gut       Date:  2005-03       Impact factor: 23.059

5.  Loss of p53 in esophageal squamous cell carcinoma and the correlation with survival: analyses of gene mutations, protein expression, and loss of heterozygosity in Japanese patients.

Authors:  Akinori Egashira; Masaru Morita; Rintaro Yoshida; Hiroshi Saeki; Eiji Oki; Noriaki Sadanaga; Yoshihiro Kakeji; Shun-Ichi Tsujitani; Yoshihiko Maehara
Journal:  J Surg Oncol       Date:  2011-04-01       Impact factor: 3.454

Review 6.  Still waiting for predictive biomarkers in Barrett's oesophagus.

Authors:  L H Moyes; J J Going
Journal:  J Clin Pathol       Date:  2011-05-23       Impact factor: 3.411

Review 7.  Genetic pathways involved in the progression of Barrett's metaplasia to adenocarcinoma.

Authors:  G J S Jenkins; S H Doak; J M Parry; F R D'Souza; A P Griffiths; J N Baxter
Journal:  Br J Surg       Date:  2002-07       Impact factor: 6.939

8.  Bone marrow progenitor cells contribute to esophageal regeneration and metaplasia in a rat model of Barrett's esophagus.

Authors:  G Sarosi; G Brown; K Jaiswal; L A Feagins; E Lee; T W Crook; R F Souza; Y S Zou; J W Shay; Stuart Jon Spechler
Journal:  Dis Esophagus       Date:  2008       Impact factor: 3.429

9.  MUC1 initiates a calcium signal after ligation by intercellular adhesion molecule-1.

Authors:  Jennifer J Rahn; Qiang Shen; Brian K Mah; Judith C Hugh
Journal:  J Biol Chem       Date:  2004-05-28       Impact factor: 5.157

10.  NSAIDs modulate CDKN2A, TP53, and DNA content risk for progression to esophageal adenocarcinoma.

Authors:  Patricia C Galipeau; Xiaohong Li; Patricia L Blount; Carlo C Maley; Carissa A Sanchez; Robert D Odze; Kamran Ayub; Peter S Rabinovitch; Thomas L Vaughan; Brian J Reid
Journal:  PLoS Med       Date:  2007-02       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.